logo
Plus   Neg
Share
Email

Genentech: Tecentriq Fails To Meet Primary Endpoint In Phase III Study

Genentech, a member of the Roche Group (RHHBY), reported that the Phase III IMvigor010 study evaluating Tecentriq as an adjuvant (after surgery) monotherapy treatment did not meet its primary endpoint of disease-free survival compared to observation in people with muscle-invasive urothelial cancer.

Genentech noted that, in addition to ongoing Phase III studies in early and advanced bladder cancer, the company has an extensive development program for Tecentriq, including multiple ongoing and planned Phase III studies across genitourinary, skin,
breast, gastrointestinal, gynecological and head and neck cancers.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
American Airlines Group has extended its offer to waive change fees for customers who purchase travel tickets through April 30, in response to lower travel demand due to the coronavirus or COVID-19 pandemic. The offer is available for any of American Airlines' published non-refundable fares. The airline had earlier waived change fees for customers who purchased tickets through April 15. The U.S. Consumer Product Safety Commission or CPSC is advancing with its proposed rule to ban padded, pillow-like crib bumpers amid increasing incidents of infant injury and deaths. In a statement, the agency said it voted unanimously last week to move forward with rulemaking on a federal safety standard for crib bumpers. Taco Bell is giving away free tacos across the United States on Tuesday, March 31 as a gesture to thank people for showing up for their communities during the coronavirus pandemic. Taco Bell is owned by Yum! Brands Inc. The Mexican-inspired restaurant chain usually offers free taco giveaways during major sporting events such as the NBA Finals or World Series.
Follow RTT
>